c-FMS inhibitor,
885704-21-2,
CHEMBL254702,
4-cyano-N-(4-(4-methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)phenyl)-1H-pyrrole-2-carboxamide,
4-Cyano-N-[4-(4-methyl-1-piperazinyl)-2-(4-methyl-1-piperidinyl)phenyl]-1H-pyrrole-2-carboxamide,
C23H30N6O,
4-Cyano-1H-pyrrole-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2-(4-methyl-piperidin-1-yl)-phenyl]-amide,
c-FMSinhibitor,
arylamide, 8,
4-cyano-N-[4-(4-methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)phenyl]-1H-pyrrole-2-carboxamide,
FMS inhibitor compound 8,
FMS inhibitor compound 1b,
MLS006010297,
SCHEMBL13405731,
BDBM27917,
CHEBI:91443,
DTXSID80470106,
DXPSQKSTVIVZLV-UHFFFAOYSA-N,
BCP21866,
4406AC,
ZINC29039424,
AKOS016012128,
CS-0838,
KS-00001D32,
NCGC00348107-01,
NCGC00348107-03,
AJ-83608,
CID 11654378,
HY-13075,
SMR004701365,
AX8246762,
W-5865,
CID11654378,
A3301,
A15043,
4-cyano-N-[4-(4-methylpiperazin-1-yl)-2-(4-methyl-1-piperidyl)phenyl]-1H-pyrrole-2-carboxamide,